The role of prokineticins in the pathogenesis of hypogonadotropic hypogonadism

Neuroendocrinology

Volumn 91, Issue 4, 2010, Pages 283-290

  Abreu, Ana Paula ^a,b   Kaiser, Ursula B ^b   Latronico, Ana Claudia ^a  

^a UNIVERSITY OF SÃO PAULO   (Brazil)

^b BRIGHAM AND WOMEN S HOSPITAL   (United States)

Author keywords

GnRH secretion; Hypogonadotropic hypogonadism; Kallmann syndrome; Prokineticins

Indexed keywords

ENDOCRINE GLAND DERIVED VASCULAR ENDOTHELIAL GROWTH FACTOR; ENDOCRINE GLAND DERIVED VASCULAR ENDOTHELIAL GROWTH FACTOR 2; G PROTEIN COUPLED RECEPTOR; GONADORELIN; GROWTH FACTOR; UNCLASSIFIED DRUG; GASTROINTESTINAL HORMONE; NEUROPEPTIDE; PROK2 PROTEIN, HUMAN; PROKR1 PROTEIN, HUMAN; PROKR2 PROTEIN, HUMAN; RECEPTOR;

ANGIOGENESIS; ATROPHY; CIRCADIAN RHYTHM; GASTROINTESTINAL MOTILITY; GENE MUTATION; GENITAL SYSTEM; HEMATOPOIESIS; HOMOZYGOSITY; HORMONE RELEASE; HUMAN; HYPOGONADOTROPIC HYPOGONADISM; HYPOPLASIA; IMMUNE RESPONSE; IN VITRO STUDY; KALLMANN SYNDROME; MORPHOGENESIS; NERVOUS SYSTEM DEVELOPMENT; NOCICEPTION; NONHUMAN; OLFACTORY BULB HYPOPLASIA; PATHOGENESIS; PHENOTYPE; PRIORITY JOURNAL; PROTEIN FUNCTION; REVIEW; SEXUAL MATURATION; ANIMAL; FEMALE; GENETICS; HYPOGONADISM; MALE; METABOLISM; MOUSE; MUTATION;

ANIMALS; FEMALE; GASTROINTESTINAL HORMONES; HUMANS; HYPOGONADISM; MALE; MICE; MUTATION; NEUROPEPTIDES; RECEPTORS, G-PROTEIN-COUPLED; RECEPTORS, PEPTIDE; VASCULAR ENDOTHELIAL GROWTH FACTOR, ENDOCRINE-GLAND-DERIVED;

EID: 77952493999     PISSN: 00283835     EISSN: None     Source Type: Journal    
DOI: 10.1159/000308880     Document Type: Review

References (38)

1. Li M, Bullock CM, Knauer DJ, Ehlert FJ, Zhou QY: Identification of two prokineticin cDNAs: recombinant proteins potently contract gastrointestinal smooth muscle. Mol Pharmacol 2001; 59: 692-698.
2. Bullock CM, Li JD, Zhou QY: Structural determinants required for the bioactivities of prokineticins and identification of prokineticin receptor antagonists. Mol Pharmacol 2004; 65: 582-588.
3. LeCouter J, Kowalski J, Foster J, Hass P, Zhang Z, Dillard-Telm L, Frantz G, Rangell L, DeGuzman L, Keller GA, Peale F, Gurney A, Hillan KJ, Ferrara N: Identification of an angiogenic mitogen selective for endocrine gland endothelium. Nature 2001; 412: 877-884.
4. Chen J, Kuei C, Sutton S, Wilson S, Yu J, Kamme F, Mazur C, Lovenberg T, Liu C: Identification and pharmacological characterization of prokineticin 2 beta as a selective ligand for prokineticin receptor 1. Mol Pharmacol 2005; 67: 2070-2076.
5. Ngan ES, Tam PK: Prokineticin-signaling pathway. Int J Biochem Cell Biol 2008; 40: 1679-1684.
6. Maldonado-Perez D, Evans J, Denison F, Millar RP, Jabbour HN: Potential roles of the prokineticins in reproduction. Trends Endocrinol Metab 2007; 18: 66-72.
7. Cheng MY, Bittman EL, Hattar S, Zhou QY: Regulation of prokineticin 2 expression by light and the circadian clock. BMC Neurosci 2005; 6: 17.
8. Cheng MY, Bullock CM, Li C, Lee AG, Bermak JC, Belluzzi J, Weaver DR, Leslie FM, Zhou QY: Prokineticin 2 transmits the behavioural circadian rhythm of the suprachiasmatic nucleus. Nature 2002; 417: 405-410.
9. Lin DC, Bullock CM, Ehlert FJ, Chen JL, Tian H, Zhou QY: Identification and molecular characterization of two closely related G protein-coupled receptors activated by prokineticins/ endocrine gland vascular endothelial growth factor. J Biol Chem 2002; 277: 19276-19280.
10. Masuda Y, Takatsu Y, Terao Y, Kumano S, Ishibashi Y, Suenaga M, Abe M, Fukusumi S, Watanabe T, Shintani Y, Yamada T, Hinuma S, Inatomi N, Ohtaki T, Onda H, Fujino M: Isolation and identification of EG-VEGF/ prokineticins as cognate ligands for two orphan G-protein-coupled receptors. Biochem Biophys Res Commun 2002; 293: 396-402.
11. Soga T, Matsumoto S, Oda T, Saito T, Hiyama H, Takasaki J, Kamohara M, Ohishi T, Matsushime H, Furuichi K: Molecular cloning and characterization of prokineticin receptors. Biochim Biophys Acta 2002; 1579: 173-179.
12. Lin R, LeCouter J, Kowalski J, Ferrara N: Characterization of endocrine gland-derived vascular endothelial growth factor signaling in adrenal cortex capillary endothelial cells. J Biol Chem 2002; 277: 8724-8729.
13. Zhang C, Truong KK, Zhou QY: Efferent projections of prokineticin 2 expressing neurons in the mouse suprachiasmatic nucleus. PLoS One 2009; 4:e7151.
14. Ng KL, Li JD, Cheng MY, Leslie FM, Lee AG, Zhou QY: Dependence of olfactory bulb neurogenesis on prokineticin 2 signaling. Science 2005; 308: 1923-1927.
15. Matsumoto S, Yamazaki C, Masumoto KH, Nagano M, Naito M, Soga T, Hiyama H, Matsumoto M, Takasaki J, Kamohara M, Matsuo A, Ishii H, Kobori M, Katoh M, Matsushime H, Furuichi K, Shigeyoshi Y: Abnormal development of the olfactory bulb and reproductive system in mice lacking prokineticin receptor PKR2. Proc Natl Acad Sci USA 2006; 103: 4140-4145.
16. Pitteloud N, Zhang C, Pignatelli D, Li JD, Raivio T, Cole LW, Plummer L, Jacobson- Dickman EE, Mellon PL, Zhou QY, Crowley WF Jr: Loss-of-function mutation in the prokineticin 2 gene causes Kallmann syndrome and normosmic idiopathic hypogonadotropic hypogonadism. Proc Natl Acad Sci USA 2007; 104: 17447-17452.
17. Cheng MY, Leslie FM, Zhou QY: Expression of prokineticins and their receptors in the adult mouse brain. J Comp Neurol 2006; 498: 796-809.
18. Prosser HM, Bradley A, Chesham JE, Ebling FJ, Hastings MH, Maywood ES: Prokineticin receptor 2 (Prokr2) is essential for the regulation of circadian behavior by the suprachiasmatic nuclei. Proc Natl Acad Sci USA 2007; 104: 648-653.
19. Hu WP, Li JD, Zhang C, Boehmer L, Siegel JM, Zhou QY: Altered circadian and homeostatic sleep regulation in prokineticin 2-deficient mice. Sleep 2007; 30: 247-256.
20. Li JD, Hu WP, Boehmer L, Cheng MY, Lee AG, Jilek A, Siegel JM, Zhou QY: Attenuated circadian rhythms in mice lacking the prokineticin 2 gene. J Neurosci 2006; 26: 11615-11623.
21. Schwanzel-Fukuda M: Origin and migration of luteinizing hormone-releasing hormone neurons in mammals. Microsc Res Tech 1999; 44: 2-10.
22. Tsai PS, Gill JC: Mechanisms of disease: insights into X-linked and autosomal-dominant Kallmann syndrome. Nat Clin Pract Endocrinol Metab 2006; 2: 160-171.
23. Albuisson J, Pecheux C, Carel JC, Lacombe D, Leheup B, Lapuzina P, Bouchard P, Legius E, Matthijs G, Wasniewska M, Delpech M, Young J, Hardelin JP, Dode C: Kallmann syndrome: 14 novel mutations in KAL1 and FGFR1 (KAL2). Hum Mutat 2005; 25: 98-99.
24. Hardelin JP, Levilliers J, Blanchard S, Carel JC, Leutenegger M, Pinard-Bertelletto JP, Bouloux P, Petit C: Heterogeneity in the mutations responsible for X chromosomelinked Kallmann syndrome. Hum Mol Genet 1993; 2: 373-377.
25. Salenave S, Chanson P, Bry H, Pugeat M, Cabrol S, Carel JC, Murat A, Lecomte P, Brailly S, Hardelin JP, Dode C, Young J: Kallmann's syndrome: a comparison of the reproductive phenotypes in men carrying KAL1 and FGFR1/KAL2 mutations. J Clin Endocrinol Metab 2008; 93: 758-763.
26. Dode C, Levilliers J, Dupont JM, De Paepe A, Le Du N, Soussi-Yanicostas N, Coimbra RS, Delmaghani S, Compain-Nouaille S, Baverel F, Pecheux C, Le Tessier D, Cruaud C, Delpech M, Speleman F, Vermeulen S, Amalfitano A, Bachelot Y, Bouchard P, Cabrol S, Carel JC, Delemarre-van de Waal H, Goulet- Salmon B, Kottler ML, Richard O, Sanchez- Franco F, Saura R, Young J, Petit C, Hardelin JP: Loss-of-function mutations in FGFR1 cause autosomal dominant Kallmann syndrome. Nat Genet 2003; 33: 463-465. (Pubitemid 36390006)
27. Falardeau J, Chung WC, Beenken A, Raivio T, Plummer L, Sidis Y, Jacobson-Dickman EE, Eliseenkova AV, Ma J, Dwyer A, Quinton R, Na S, Hall JE, Huot C, Alois N, Pearce SH, Cole LW, Hughes V, Mohammadi M, Tsai P, Pitteloud N: Decreased FGF8 signaling causes deficiency of gonadotropin-releasing hormone in humans and mice. J Clin Invest 2008; 118: 2822-2831.
28. Kim HG, Kurth I, Lan F, Meliciani I, Wenzel W, Eom SH, Kang GB, Rosenberger G, Tekin M, Ozata M, Bick DP, Sherins RJ, Walker SL, Shi Y, Gusella JF, Layman LC: Mutations in CHD7, encoding a chromatin-remodeling protein, cause idiopathic hypogonadotropic hypogonadism and Kallmann syndrome. Am J Hum Genet 2008; 83: 511-519.
29. Dodé C, Teixeira L, Levilliers J, Fouveaut C, Bouchard P, Kottler ML, Lespinasse J, Lienhardt- Roussie A, Mathieu M, Moerman A, Morgan G, Murat A, Toublanc JE, Wolczynski S, Delpech M, Petit C, Young J, Hardelin JP: Kallmann syndrome: mutations in the genes encoding prokineticin-2 and prokineticin receptor-2. PLoS Genet 2006; 2:e175.
30. Abreu AP, Trarbach EB, de Castro M, Frade Costa EM, Versiani B, Matias Baptista MT, Garmes HM, Mendonca BB, Latronico AC: Loss-of-function mutations in the genes encoding prokineticin-2 or prokineticin receptor-2 cause autosomal recessive Kallmann syndrome. J Clin Endocrinol Metab 2008; 93: 4113-4118.
31. Leroy C, Fouveaut C, Leclercq S, Jacquemont S, Boullay HD, Lespinasse J, Delpech M, Dupont JM, Hardelin JP, Dode C: Biallelic mutations in the prokineticin-2 gene in two sporadic cases of Kallmann syndrome. Eur J Hum Genet 2008; 16: 865-868.
32. Sinisi AA, Asci R, Bellastella G, Maione L, Esposito D, Elefante A, De Bellis A, Bellastella A, Iolascon A: Homozygous mutation in the prokineticin-receptor2 gene (Val274Asp) presenting as reversible Kallmann syndrome and persistent oligozoospermia: case report. Hum Reprod 2008; 23: 2380-2384.
33. Canto P, Munguia P, Soderlund D, Castro JJ, Mendez JP: Genetic analysis in patients with Kallmann syndrome: coexistence of mutations in prokineticin receptor 2 and KAL1. J Androl 2009; 30: 41-45.
34. Cole LW, Sidis Y, Zhang C, Quinton R, Plummer L, Pignatelli D, Hughes VA, Dwyer AA, Raivio T, Hayes FJ, Seminara SB, Huot C, Alos N, Speiser P, Takeshita A, Van Vliet G, Pearce S, Crowley WF Jr, Zhou QY, Pitteloud N: Mutations in prokineticin 2 and prokineticin receptor 2 genes in human gonadotrophin- releasing hormone deficiency: molecular genetics and clinical spectrum. J Clin Endocrinol Metab 2008; 93: 3551-3559.
35. Chan YM, de Guillebon A, Lang-Muritano M, Plummer L, Cerrato F, Tsiaras S, Gaspert A, Lavoie HB, Wu CH, Crowley WF Jr, Amory JK, Pitteloud N, Seminara SB: GNRH1 mutations in patients with idiopathic hypogonadotropic hypogonadism. Proc Natl Acad Sci USA 2009; 106: 11703-11708.
36. Sarfati J, Guiochon-Mantel A, Rondard P, Arnulf I, Garcia-Pinero A, Wolczynski S, Brailly-Tabard S, Bidet M, Arroyo R, Mathieu M, Lienhardt-Roussie A, Morgan G, Turki Z, Bremont C, Lespinasse J, Du Boullay H, Chabbert-Buffet N, Jacquemont S, Reach G, De Talence N, Tonella P, Conrad B, Despert F, Delobel B, Brue T, Bouvattier C, Cabrol S, Pugeat M, Murat A, Bouchard P, Hardelin JP, Dode C, Young J: A comparative phenotypic study of kallmann syndrome patients carrying monoallelic and biallelic mutations in the prokineticin 2 or prokineticin receptor 2 genes. J Clin Endocrinol Metab 2010; 95: 659-669.
37. Monnier C, Dode C, Fabre L, Teixeira L, Labesse G, Pin JP, Hardelin JP, Rondard P: PROKR2 missense mutations associated with Kallmann syndrome impair receptor signalling activity. Hum Mol Genet 2009; 18: 75-81.
38. Wechselberger C, Puglisi R, Engel E, Lepperdinger G, Boitani C, Kreil G: The mammalian homologues of frog Bv8 are mainly expressed in spermatocytes. FEBS Lett 1999; 462: 177-181.